Company / Share Buybacks
Regeneron Pharmaceuticals Share Buybacks History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Share Buybacks
$3.4B
FY2025
5-year range
$275.9M / $5.8B
FY2021-FY2025
Trend
+32.1%
vs FY2024
Sector context
#4 of 48
Health Care
What the data says
Among 48 Health Care companies, Regeneron Pharmaceuticals is in the top 8% for share buybacks. Share Buybacks has fluctuated over the past 10 years, ranging from $0 in FY2017 to $5.8B in FY2022.
Based on SEC 10-K filings.
$3.4B in FY2025 with a 5-year CAGR of +279.0%. Top quartile in the Health Care sector.
Improved from $2.2B to $3.4B over the past 2 years.
Health Care sector context is included.
Share Buybacks over time
Growth rates
- 3-Year CAGR
- -16.2%
- 5-Year CAGR
- +279.0%
- 10-Year CAGR
- -
Sector benchmark
Top 8% in Health CareTop 8% of 48This company $3.4B Sector average $611.9M
▼
+462.0% above sector average
Key checks
Key Insights
- 5-year CAGR of +279.0%, indicating consistent growth.
- In FY2025, share buybacks increased 32.1% year-over-year.
- Ranks #4 out of 48 companies in the Health Care sector.
- Peak share buybacks was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 3.03 (safe zone, above 2.9 threshold)
- Strong profit margin: 32.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Share BuybacksValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.4B | +32.1% |
| FY2024 | $2.6B | +16.5% |
| FY2023 | $2.2B | -61.8% |
| FY2022 | $5.8B | +2019.2% |
| FY2021 | $275.9M | +6170.5% |
| FY2020 | $4.4M | -98.4% |
| FY2019 | $275.9M | +6170.5% |
| FY2018 | $4.4M | - |
| FY2017 | $0 | - |
| FY2016 | $0 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026